Active Breast and Gynecologic Cancer Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Araneta, Maria Rosario Gorrez University Of California, San Diego 12/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers
Bae-Jump, Victoria Lin Univ Of North Carolina Chapel Hill Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer PA-17-073: Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies
Barroilhet, Lisa M University Of Wisconsin-Madison Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Boyer, Thomas G University Of Texas Hlth Science Center Pathological reprogramming of the m6A epitranscriptome in uterine fibroids PAR-18-830: The Role of Epitranscriptomics in Development and Disease
Brown, Angela Washington University 17/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers
Brown, Kristy Weill Medical Coll Of Cornell Univ Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Chibwesha, Carla J Univ Of North Carolina Chapel Hill Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Crandall, Jill P Albert Einstein College Of Medicine 20/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers
Cremer, Miriam Cleveland Clinic Lerner Com-Cwru Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE) PAR-18-530: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
Crew, Katherine D Columbia University Health Sciences Multicenter trial of decision support for breast cancer chemoprevention PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Dabelea, Dana University Of Colorado Denver 6/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers
Degnim, Amy C Mayo Clinic Rochester Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Dryden-Peterson, Scott Lee Brigham And Women'S Hospital Covid-19-related cervical cancer treatment interruption and role of neoadjuvant chemotherapy PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
D.Sc., Samuel Dagogo-Jack, M.D., University Of Tennessee Health Sci Ctr 9/22 Limited Competition for Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers
Ehrmann, David A University Of Chicago 2/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center DPPOS Study RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers

Pages